To screen ETFs by asset class, performance, yield and more, check out the
Roy Manning III
has sold off alot. I would consider it a buy now. News on a Gout drug partner or their Hep
. patent could push the stock higher.
Add a reply...
Latest StockTalks »
people get BCRX breaking news and analysis by email alert.
Get email alerts on BCRX »
BioCryst Pharmaceuticals, Inc.
Get latest price
From other sites
BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst Blog
at Zacks.com (Jan 15, 2015)
Need to Know: Investors face ‘the worst time ever’ to buy stocks
at MarketWatch.com (Jan 14, 2015)
Pharmacyclics (PCYC) Looks Good: Stock Moves 16.4% Up - Tale of the Tape
at Zacks.com (Jan 14, 2015)
Benzinga's Top #PreMarket Gainers
at Benzinga.com (Jan 14, 2015)
Chimerix tackles Ebola outbreak
at CNBC.com (Jan 13, 2015)
Xignite quote data
© 2015 Seeking Alpha